WO2022042478A1 - Anti-detachment anchoring mechanism applied to implanted prosthesis - Google Patents

Anti-detachment anchoring mechanism applied to implanted prosthesis Download PDF

Info

Publication number
WO2022042478A1
WO2022042478A1 PCT/CN2021/114062 CN2021114062W WO2022042478A1 WO 2022042478 A1 WO2022042478 A1 WO 2022042478A1 CN 2021114062 W CN2021114062 W CN 2021114062W WO 2022042478 A1 WO2022042478 A1 WO 2022042478A1
Authority
WO
WIPO (PCT)
Prior art keywords
anchoring
dropping
detachment
area
anchoring mechanism
Prior art date
Application number
PCT/CN2021/114062
Other languages
French (fr)
Chinese (zh)
Inventor
吕世文
陈志�
陶永昶
陈进雄
Original Assignee
宁波健世生物科技有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 宁波健世生物科技有限公司 filed Critical 宁波健世生物科技有限公司
Publication of WO2022042478A1 publication Critical patent/WO2022042478A1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/24Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body

Definitions

  • the invention relates to the field of medical devices, in particular to an anti-dropping anchoring mechanism applied to an implanted prosthesis.
  • the anatomical structure of the mitral valve is complex, including leaflets, annulus, chordae tendineae and papillary muscles, which play an important role in the maintenance of left and right ventricular function, respectively.
  • Any structurally intact and functional disorder affecting the valve leaflets, annulus, chordae tendineae, papillary muscles, and left ventricle can lead to severe mitral regurgitation (MR), which can lead to left ventricular failure, pulmonary hypertension , atrial fibrillation, stroke and death.
  • mitral regurgitation is the type of valvular disease with the highest incidence in the elderly over 65 years old.
  • Mitral regurgitation can be divided into degenerative MR and functional MR.
  • Degenerative MR is caused by pathological changes in one or more of the valve leaflets, valve annulus, chordae tendineae and papillary muscles; functional MR is usually left ventricular function Abnormalities, such as annulus enlargement, but the mitral valve is usually normal.
  • the treatment methods of MR mainly include drug therapy, surgery and interventional therapy.
  • Drug treatment can only improve the patient's symptoms, but cannot prolong the patient's survival time.
  • Surgery primarily valve repair or valve replacement, is recognized as the treatment of choice for mitral regurgitation and has been shown to relieve symptoms and prolong life.
  • the surgical risk is high and the survival benefit is low.
  • the surgical success rate of such patients is only 50%, and the surgical success rate of patients with severe functional MR is even higher. as low as 16%. Therefore, transcatheter interventional mitral valve repair and replacement could theoretically benefit high-risk patients who have lost the opportunity for surgery.
  • Interventional therapy is to load the artificial implant on the delivery system in vitro, along the vascular path or puncture the apex to deliver the mitral valve annulus, and then release and fix it to completely or partially replace the function of the native valve.
  • mitral valve interventional therapy has become one of the research hotspots in related fields, and many products are under research and development.
  • the development of mitral valve interventional devices faces many special difficulties.
  • Patent CN201880035165.9 discloses a minimally invasive implantable device and a mitral valve implant system, comprising a device (10) having an annuloplasty ring (11), wherein the annuloplasty ring (11) :- has at least one tissue anchor (15);- is deformable between a delivery configuration (57) and an open configuration (X) in which the annuloplasty ring (11) is compressed to sized and inserted into the left atrium (12), in the open configuration, the annuloplasty ring (11) is expanded to its original initial shape (58) to impact the anatomical opening (9) and is secured at the anatomical opening ; - generally annular, having an inner layer for stabilization and at least one outer envelope through which at least one artificial thread (33) is drawn; and - having a circular ring body (27), said circular annulus (27);- having an anterior portion (20) engaging the tissue anchor position (24) of the anterior side (31) of the mitral valve annulus (13) of the anterior leaflet (16), and- Tissue anchor location (24) of the posterior side (32) of the
  • This technical solution uses a "spiral anchoring needle” to fix the annuloplasty ring at the annulus position of the mitral valve... And with the repeated beating of the heart, the "spiral anchoring needle” and the annuloplasty The rings are prone to loosening, causing the anchoring pin to fall off the annuloplasty ring, resulting in failure of the implanted prosthesis.
  • Patent CN201910354329.0 discloses a device for reducing the opening area of the mitral valve annulus.
  • the device includes an anchoring member, a blocking member and a connecting rope.
  • the anchoring member is adapted to be connected with the mitral valve annulus.
  • the blocking member It has two discs, there is a gap between the two discs, and the two discs are located on both sides of the interatrial septum, so as to realize the connection between the blocking piece and the interatrial septum, and the two ends of the connecting rope are respectively connected to the anchor piece and the blocking piece.
  • the connection is made by adjusting the distance between the anchor and the occluder, so as to adjust the opening area of the mitral valve annulus.
  • the device uses a connecting rope to connect the anchoring piece and the blocking piece, so that the distance between the anchoring piece and the blocking piece can be adjusted easily, and the function of reducing the opening area of the mitral valve annulus is better achieved.
  • the direct connection of the anchoring piece on the mitral valve annulus reduces the adverse effect of the device on the vein and improves the safety of the device in use.
  • the anchors used in the technical solution are commonly used "spiral" or "double hook", and after long-term implantation of the prosthesis, the anchors are not designed to further lock the structure to make the anchoring more reliable. , the beating of the heart can easily disengage the anchor from the annulus.
  • the anchors are used to fix the prosthesis in the patient's heart in the technical solutions described above, since the anchors are not designed with a further locking function to make the anchoring effect more reliable, Therefore, in the process of continuous beating of the heart, the anchoring piece is easily detached from the anchoring area to which it belongs, resulting in the loss of the fixation point of the prosthesis.
  • the purpose of the present invention is to provide an anti-detachment anchoring mechanism applied to an implanted prosthesis, and the valve prosthesis has the following advantages: the anchoring member passes through the anchoring area and is connected with the cardiac tissue, so that the stent is fixed in the heart At the same time, after passing through the anchoring area, the anti-detachment piece is finally connected to the anchoring area, so that the anti-detachment anchoring mechanism is locked on the anchoring area, so as to prevent the anchoring piece from loosening and detaching from the anchoring area;
  • an anti-dropping anchoring mechanism applied to an implanted prosthesis comprising an implanted prosthesis, a pushing device and an anti-dropping anchor arranged in the pushing device
  • An anchoring mechanism the anti-dropping anchoring mechanism includes an anchor piece and an anti-dropping piece, one end of the anchor piece is connected with one end of the anti-dropping piece, and the pushing device pushes the anti-dropping anchoring mechanism and makes the anchor
  • the other end of the fixing piece passes through the anchoring area and is matched with the heart tissue, and when the anti-dropping anchoring mechanism is further pushed, the other end of the anti-dropping piece passes through the anchoring area and then folds back and finally connects with the heart tissue.
  • the anchor regions form two or more attachment points.
  • the pushing device includes a delivery catheter and a push rod
  • the push rod and the anti-detachment anchoring mechanism are arranged in the delivery catheter
  • the anti-detachment anchoring mechanism is arranged on the side of the push rod.
  • the push rod pushes the anti-detachment anchoring mechanism and makes the other end of the anchor pass through the anchoring area and is connected with the heart tissue, and when the push rod further pushes the anti-detachment anchoring mechanism , the other end of the anti-falling piece passes through the anchoring area and then folds back and finally forms two or more connection points with the anchoring area.
  • the length of the anchoring member is greater than the length of the anti-falling member.
  • both the anchoring member and the anti-falling member have a predetermined shape.
  • the anchors are one or more arcuate anchoring needles.
  • the anchoring member may be one or more anchoring needles in a helical structure.
  • the anti-falling element can be one or more arc-shaped anchoring needles.
  • the anti-shedding member may be one or more anchoring needles in a helical structure.
  • the anti-dropping member may be one or more arc-shaped anchoring needles.
  • the anti-dropping member may be one or more anchoring needles of helical structure.
  • the anchoring member can be one or more anchoring needles of helical structure
  • the anti-dropping member can be one or more arc-shaped anchoring needles.
  • the anchoring member can be one or more anchoring needles with a helical structure
  • the anti-dropping member can be one or more anchoring needles with a helical structure.
  • the anchoring region is covered with a film
  • the film material includes metal material, polytetrafluoroethylene, polyethylene, polypropylene, polyester or animal-derived material.
  • the stent further comprises an atrial segment disposed distally of the valve suture segment, and the anchoring region is disposed on the atrial segment.
  • the stent further comprises a fixation device on which the anchoring region is disposed, and one end of the fixation device is connected to the proximal end portion of the valve suture segment.
  • one end of the push rod is detachably connected to the anti-dropping anchoring mechanism.
  • the other end of the anchoring member is connected to the valve suture segment after passing through the anchoring region and the cardiac tissue.
  • the other end of the anchor passes through the anchoring region, the heart tissue, behind the valve sewing segment and is between the prosthetic valve and the valve sewing segment.
  • the other end of the anti-falling element is finally connected to the anchoring region.
  • the anti-dropping anchoring mechanism further includes a limiting member, and one end of the anchoring member and one end of the anti-dropping member are respectively fixedly connected to the limiting member.
  • the end of the other end of the anchoring member is provided with a barb structure or the anchoring member is evenly provided with micro-thorns.
  • the end of the other end of the anti-dropping member is provided with a barb structure or the anti-dropping member is evenly provided with micro-thorns.
  • the anchoring member in the present invention is connected with the heart tissue through the anchoring area, so that the stent is fixed in the heart, and at the same time, after the anti-dropping member passes through the anchoring area, it finally forms two connection points with the anchoring area;
  • the stent loses its fixed point, and the anti-detachment member of the present invention has two or more stress points on the anchoring area, so that when the stent is impacted by blood flow, the anti-detachment member can disperse/dissolve the impact force. to 2 or more stress points, thereby reducing the stress of the anchor, so that the anti-drop anchor mechanism is locked on the anchor area, preventing the anchor from loosening relative to the anchor area and from the anchor area. disengagement;
  • the length of the main locking piece in the present invention is greater than the length of the auxiliary locking piece.
  • Coronary venous sinus and other cardiac tissues avoiding damage or tearing of intracardiac tissues; at the same time, the shorter anti-dropping parts have smaller torque, and are less prone to deformation and pull-off, which can make the anti-dropping anchoring mechanism and anchoring The locking of the area is more stable;
  • One end of the push rod in the present invention is detachably connected to the anti-dropping anchoring mechanism.
  • the push rod pushes and anchors the anti-dropping anchoring mechanism to the target position, the push rod can be evacuated from the human body, which greatly reduces the Implants that reduce contact and stimulation of the atrium and facilitate the evacuation of the delivery system from the body;
  • the anchoring piece passes through the anchoring area, passes through the heart tissue and is connected with the valve suture segment.
  • the purpose of this design is: both ends of the anchoring piece are connected with the stent, so that the two are connected to each other. As a whole, it is not easy to loosen between the relative stents after the anchors are implanted, so as to avoid the pull-off/detachment of the anchors from the anchoring area;
  • the auxiliary locking member is finally connected to the anchoring area after passing through the anchoring area and the heart tissue.
  • the advantage of this design is that the anti-dropping member needs to pass through the heart tissue and finally connect to the anchoring area, so that the anti-dropping member needs to pass through the heart tissue and finally connect to the anchoring area. While locked in the anchoring area, it is connected with part of the heart tissue, further consolidating the anchoring effect of the anti-dropping piece;
  • the other end of the anchoring piece and the other end of the anti-dropping piece are both provided with a barb structure or the anchoring piece and the other end of the anti-dropping piece are evenly provided with a micro-thorn structure.
  • the anchoring effect of the de-anchoring mechanism can more effectively avoid the pull-off/detachment of the anti-detachment anchoring mechanism from the anchoring area.
  • FIG. 1a-1b are schematic diagrams of the overall structure of the present invention.
  • Figures 2a-2e are schematic diagrams of the process of implanting the anchorage by the anti-dropping anchoring mechanism.
  • Figures 3a-3b are schematic diagrams of the structure of the anchoring member forming the connection point in the anchoring section.
  • 4a-4m are schematic structural diagrams of various embodiments of the anti-dropping anchoring mechanism.
  • 5a-5c are schematic diagrams of various structures of the connection between the anti-dropping anchoring mechanism and the cardiac tissue.
  • 6a-6b are schematic structural diagrams of another embodiment of the anti-dropping anchoring mechanism.
  • the proximal end refers to the end close to the apex of the heart
  • the distal end refers to the end away from the apex of the heart.
  • an anti-detachment anchoring mechanism applied to an implanted prosthesis includes a valve prosthesis 1, a pushing device 3, and a pushing device disposed on the pushing device
  • the anti-detachment anchoring mechanism 2 in 3 the valve prosthesis 1 comprises a valve sewing segment 11 atrial segment 12 and an anchoring region 13, the atrial segment 12 is arranged at the distal end of the valve sewing segment 11,
  • the anchoring region 13 is arranged on the atrium segment 12 , and the anchoring region 13 is provided with an anti-dropping anchoring mechanism 2
  • the anti-dropping anchoring mechanism 2 includes an anchoring member 21 and a falling-off preventing member 22 .
  • one end of the anchoring member 21 is fixedly connected with one end of the anti-dropping member 22 , as shown in FIGS. 2 a to 2 e , the push rod 32 located in the delivery catheter 31 pushes the anti-dropping anchoring mechanism 2 and makes the The other end of the anchoring member 21 passes through the anchoring area 13 and is connected to the cardiac tissue, and further pushes the anti-dropping anchoring mechanism 2; as shown in FIG. 3a, the other end of the anti-dropping member 22 passes through the The anchoring area 13 is folded back and finally forms two connection points with the anchoring area 13.
  • the anti-dropping member 22 restricts the anchoring member 21 from leaving the anchoring area 13; the anchoring member 21 passes through the anchoring area.
  • the valve prosthesis further includes a pushing device 3, the pushing device 3 includes a delivery catheter 31 and a push rod 32, the push rod 32 and the anti-drop anchoring mechanism 2 Set in the delivery catheter 31, the anti-detachment anchoring mechanism 2 is set on the distal end side of the push rod 32.
  • the push rod 32 pushes the anti-detachment anchoring mechanism 2
  • the The other end of the anchoring member 21 passes through the anchoring area 13 and is connected with the heart tissue.
  • the push rod 32 is pushed further, the other end of the anti-dropping member 22 passes through the anchoring area 13 and finally connects with the anchor.
  • the anchoring area 13 is matched and connected, and the disengagement prevention member 22 restricts the anchoring member 21 from being separated from the anchoring area 13 .
  • the pushing device 3 pushes the anti-detachment anchoring mechanism 2 and makes the other end of the anchoring piece 21 pass through the anchoring area 13 to be connected with the cardiac tissue, and further push the anti-detachment anchoring mechanism 2 .
  • the anchoring mechanism 2 is disengaged; as shown in FIG. 3b, the other end of the disengagement prevention member 22 passes through the anchoring area 13 and then folds back to form three connection points with the anchoring area 13. 22 restricts the anchoring member 21 from disengaging from the anchoring region 13 .
  • the anchoring region 13 is covered with a film, and the film material includes metal material, polytetrafluoroethylene, polyethylene, polypropylene, polyester, or animal-derived material.
  • the length of the anchoring member 21 is greater than the length of the anti-dropping member 22 ; the advantage of this design is that the main locking member fixes the stent 1 and the tissue, and the anti-dropping member 22 passes through the anchoring area 13 and Finally, it is connected with the anchoring area 13 so that the anti-dropping anchoring mechanism 2 is locked on the anchoring area 13, and the length of the auxiliary locking member is short, so it will not hook or compress the nerve bundle during the anchoring/locking process, Coronary venous sinus and other cardiac tissues can avoid damage or tearing of intracardiac tissues; at the same time, the shorter anti-dropping member 22 has a smaller torque and is less prone to deformation and pull-off, which can make the anti-dropping anchoring mechanism 2 and the The locking of the anchoring area 13 is more secure.
  • the shape of the other end of the anchoring member 21 may be a spiral structure; similarly, the shape of the other end of the anti-dropping member 22 may also be a spiral structure, as shown in FIG. 4a , when When the shape of the other end of the anti-dropping member 22 is a helical structure, the anti-dropping member 22 and the anchoring area will form four connection points to further ensure that the anti-dropping member 22 will not be detached from the anchoring area 13.
  • the anti-detachment member 22 can disperse/dissolve the impact force to these four stress points, thereby reducing the force of the anchoring member 21 and making the anti-detachment anchoring mechanism 2 is locked on the anchoring area 13 to prevent the anchoring piece 21 from loosening relative to the anchoring area 13 and detaching from the anchoring area 13 .
  • the other end of the anti-dropping member 22 may be provided with a plurality of sharp parts, as shown in FIG. 4b , the other end of the anti-dropping member 22 passes through the anchoring area 13 and then is folded back and finally A plurality of connection points are formed with the anchoring region 13 .
  • the anti-detachment anchoring mechanism 2 is further provided with a connecting section, as shown in FIG. 4c , the connecting section is arranged in an arc structure, and one end of the anchoring member 21 is connected to the connecting section. A segment is connected, and one end of the anti-falling member 22 is connected with the connection segment.
  • both the anchoring member 21 and the anti-dropping member 22 have a preset shape; when the anchoring member 21 is one or more arc-shaped anchoring needles , the anti-dropping member 22 can be one or more arc-shaped anchoring needles.
  • the anti-dropping member 22 can be one or more anchors of helical structure Fixed needle.
  • the anchoring member 21 can be one or more anchoring needles of helical structure
  • the anti-dropping member 22 can be one or more arc-shaped anchors Fixed needle.
  • the anchoring member 21 when the anchoring member 21 can be one or more anchoring needles in helical structure, the anti-dropping member 22 can be one or more helical structures Anchoring needle of the like structure.
  • the anti-dropping anchoring mechanism 2 further includes a limiting member 4. As shown in Figures 4j to 4m, one end of the anchoring member 21 and one end of the anti-dropping member 22 are respectively connected to the limiting member 4. Piece 4 is fixedly connected.
  • one end of the push rod 32 is detachably connected to the anti-detachment anchoring mechanism 2 ; specifically, one end of the push rod 32 is movably connected to the limiting member 4 (the connection method can adopt a known technology , such as rope sets, slip knots, etc.), after confirming that the anchoring effect of the anti-fall anchoring mechanism 2 is ideal, remove the above-mentioned movable connection, and then the pushing device 3 (including the delivery catheter 31 and the pushing The rod 32) is withdrawn from the human body, and the advantage of this design is that it can reduce the volume of the implant and reduce the risk of thrombosis.
  • the other end of the anchoring member 21 is connected to the valve sewing segment 11 after passing through the anchoring region 13 and the heart tissue; more preferably, the other end of the anchoring member 21 is One end passes through the anchoring region 13, the heart tissue, and the valve sewing segment 11 and is between the prosthetic valve (not shown) and the valve sewing segment 11; the purpose of this design is that both ends of the anchoring member 21 are connected to the stent. 1 is connected, so that the two are connected as a whole, and the relative stent 1 is not easily loosened after the anchor 21 is implanted, so as to avoid the situation that the anchor 21 is pulled/detached from the anchor area 13 .
  • the other end of the anti-dropping member 22 passes through the anchoring region 13 and the heart tissue, it is finally connected to the anchoring region 13; the advantages of this design are: 22 needs to be finally connected to the anchoring area 13 after passing through the heart tissue, so that the anti-shedding member 22 is locked in the anchoring area 13 and connected with part of the heart tissue, further consolidating the anchoring effect of the anti-falling member 22; the same As shown in FIG. 5b, the other end of the anchoring member 21 can be passed through the anchoring region 13, the heart tissue, behind the valve sewing segment 11 and between the prosthetic valve (not shown) and the valve sewing segment 11. , and the other end of the anti-dropping member 22 is finally connected to the anchoring region 13 after passing through the anchoring region 13 and the cardiac tissue.
  • the other end of the anchoring member 21 is provided with a barb structure 5 or the anchoring member 21 is evenly provided with micro-thorns 6; the anchoring member can be further increased
  • the anchoring effect of 21 can more effectively avoid the pull-off/detachment of the anchoring member 21 from the anchoring area 13 .
  • the end of the other end of the anti-dropping member 22 is provided with a barb structure 5 or the anti-dropping member 22 is evenly provided with micro-thorns 6; the advantages of this design are: The locking effect of the anti-releasing member 22 can be further increased, and the situation that the anchoring member 21 is pulled/detached from the anchoring area 13 is more effectively avoided.
  • an anti-detachment anchoring mechanism applied to an implanted prosthesis includes a stent 1 and a prosthetic valve (not shown), the stent 1 It includes a valve sewing segment 11, a fixing device 7 and an anchoring area 13, the anchoring area 13 is set on the fixing device 7, and the anchoring area 13 is provided with an anti-detachment anchoring mechanism 2, the One end of the fixation device 7 is connected to the proximal end portion of the valve sewing segment 11 , and the other end of the fixation device 7 is close to the patient's ventricular septum.
  • the valve prosthesis is placed on the patient's ventricular septum and the axial movement of the valve prosthesis is restricted.
  • the other end of the anchoring member 21 passes through the anchoring area 13 and is connected with the heart tissue, and the other end of the anti-dropping member 22 passes through the anchoring area 13 and then is folded back and finally forms two parts with the anchoring area 13 .
  • the anchoring member 22 restricts the anchoring member 21 from being separated from the anchoring area 13; the anchoring member 21 is connected to the heart tissue through the anchoring area 13, so that the stent 1 is fixed in the heart, while preventing from falling off.
  • the component 22 After passing through the anchoring area 13, the component 22 is finally connected to the anchoring area 13, so that the anti-dropping anchoring mechanism 2 is locked on the anchoring area 13, so as to prevent the anchoring component 21 from loosening relative to the anchoring area 13 and removing the anchoring area from the anchoring area 13. 13 on the case of disengagement.
  • the valve prosthesis further includes a pushing device 3, and the pushing device 3 includes a delivery catheter 31 and a push rod 32, and the push rod 32 and the anti-detachment anchoring mechanism 2 are provided in the delivery In the catheter 31 , when the push rod 32 pushes the anti-detachment anchoring mechanism 2 , the other end of the anchor 21 passes through the anchoring area 13 and is connected with the cardiac tissue, and when the push rod 32 is further pushed , the other end of the anti-dropping member 22 passes through the anchoring area 13 and is finally connected with the anchoring area 13 , and the anti-dropping member 22 restricts the anchoring member 21 from being separated from the anchoring area 13 .
  • the length of the anchoring member 21 is greater than the length of the anti-dropping member 22 ; the advantage of this design is that the main locking member fixes the stent 1 and the tissue, and the anti-dropping member 22 passes through the anchoring area 13 and The final connection with the anchoring area 13 makes the anti-detachment anchoring mechanism 2 locked on the anchoring area 13, and the length of the auxiliary locking piece is short, so it will not affect other cardiac tissues during the anchoring/locking process, avoiding the need for The intracardiac tissue is damaged or torn; at the same time, the shorter anti-dropping member 22 has a smaller torque and is less likely to be deformed and pulled off, which can make the locking of the anti-dropping anchoring mechanism 2 and the anchoring region 13 more stable.
  • both the anchoring member 21 and the anti-dropping member 22 have preset shapes; when the anchoring member 21 is one or more arc-shaped anchoring needles, the anti-dropping member 22 can be Anchor pins for one or more arcs.
  • the anti-dropping member 22 can be one or more anchoring needles of helical structure.
  • the anchoring member 21 can be one or more anchoring needles of helical structure
  • the anti-dropping member 22 can be one or more arc-shaped anchoring needles.
  • the anchoring member 21 can be one or more anchoring needles with a helical structure
  • the anti-dropping member 22 can be one or more anchoring needles with a helical structure.
  • the anti-dropping anchoring mechanism 2 further includes a limiting member 4 , and one end of the anchoring member 21 and one end of the anti-dropping member 22 are respectively fixedly connected to the limiting member 4 .
  • one end of the push rod 32 is detachably connected to the anti-detachment anchoring mechanism 2 ; specifically, one end of the push rod 32 is movably connected to the limiting member 4 (the connection method can adopt a known technology , such as rope sets, slip knots, etc.), after confirming that the anchoring effect of the anti-fall anchoring mechanism 2 is ideal, remove the above-mentioned movable connection, and then the pushing device 3 (including the delivery catheter 31 and the pushing The rod 32) is withdrawn from the human body, and the advantage of this design is that it can reduce the volume of the implant and reduce the risk of thrombosis.
  • the end of the other end of the anchoring member 21 is provided with a barb structure 5 or the anchoring member 21 is evenly provided with micro-thorns 6; the anchoring effect of the anchoring member 21 can be further increased, It is more effective to avoid the pull-off/detachment of the anchoring member 21 from the anchoring region 13 .
  • the end of the other end of the anti-dropping member 22 is provided with a barb structure 5 or the anti-dropping member 22 is evenly provided with micro-thorns 6; the advantage of this design is that the anti-dropping member can be further increased.
  • the locking effect of 22 can more effectively avoid the pull-off/detachment of the anchoring member 21 from the anchoring area 13 .
  • the anti-detachment anchoring mechanism of the present invention can be applied not only in the field of heart valve prostheses, but also in some other implanted prostheses that require anchoring mechanisms/anchoring devices; for example, in the field of occlusion
  • the anti-detachment anchoring mechanism can be anchored on the head of the occluder, so that the occluder can better fit the heart tissue and further improve the occlusion effect of the occluder.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Surgery (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Transplantation (AREA)
  • Reproductive Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Prostheses (AREA)

Abstract

An anti-detachment anchoring mechanism (2) applied to a valve prosthesis (1), comprising a valve prosthesis (1), a pushing device (3), and an anti-detachment anchoring mechanism (2); the valve prosthesis (1) comprises a valve stitching section (11) and an anchoring area (13); the anti-detachment anchoring mechanism (2) comprises an anchoring member (21) and an anti-detachment member (22), one end of the anchoring member (21) being connected to one end of the anti-detachment member (22); the pushing device (3) pushes the anti-detachment anchoring mechanism (2) and enables the other end of the anchoring member (21) to pass through the anchoring area (13) and cooperatively connect to the heart tissue; when the anti-detachment anchoring mechanism (2) is further pushed, the other end of the anti-detachment member (22) passes through the anchoring area (13) and then folds back and finally forms two or more connection points with the anchoring area (13); the anchoring member (21) passes through the anchoring area (13) to cooperatively connect to the heart tissue, so that the valve prosthesis (1) is fixed within the heart; meanwhile, the anti-detachment member (22) passes through the anchoring area (13) and then is finally connected to the anchoring area (13), so that the anti-detachment anchoring mechanism (2) is locked in the anchoring area (13), preventing the situation in which the anchoring member (21) loosens relative to the anchoring area (13) and detaches from the anchoring area (13).

Description

一种应用在植入假体上的防脱锚定机构An anti-drop anchoring mechanism applied to implanted prostheses
本申请要求于2020年8月31日在中国提交的申请号为CN202021856849.6的中国实用新型专利申请“一种应用在植入假体上的防脱锚定机构”的优先权,该中国申请的全部内容通过引用结合于本申请中。This application claims the priority of the Chinese utility model patent application "A kind of anti-dropping anchoring mechanism applied to implanted prosthesis" with the application number CN202021856849.6 filed in China on August 31, 2020. The Chinese application The entire contents of is incorporated herein by reference.
技术领域technical field
本发明涉及医疗器械领域,尤其涉及一种应用在植入假体上的防脱锚定机构。The invention relates to the field of medical devices, in particular to an anti-dropping anchoring mechanism applied to an implanted prosthesis.
背景技术Background technique
二尖瓣解剖结构复杂,包含瓣叶、瓣环、腱索与乳头肌,分别对左、右心室功能的维持起着重要作用。任何影响到瓣叶、瓣环、腱索、乳头肌和左心室的结构完整和功能正常的疾病都可能导致严重的二尖瓣关闭不全(mitral regurgitation,MR),可引起左心室衰竭、肺动脉高压、心房颤动、脑卒中和死亡。根据美国等西方发达国家的最新流行病学调查数据显示,在大于65岁以上的老年人群发病率占首位的瓣膜病类型是二尖瓣反流。目前,我国虽然还没有权威性的流行病学调查数据,但随着人口老龄化的来临,我国二尖瓣反流患者的数量之庞大是毋庸置疑的。二尖瓣关闭不全可分退行性MR和功能性MR,退行性MR是由瓣叶、瓣环、腱索和乳头肌的1项或以上发生病理学改变引起;功能性MR通常为左心室功能异常,例如瓣环扩大,但二尖瓣瓣膜通常是正常的。The anatomical structure of the mitral valve is complex, including leaflets, annulus, chordae tendineae and papillary muscles, which play an important role in the maintenance of left and right ventricular function, respectively. Any structurally intact and functional disorder affecting the valve leaflets, annulus, chordae tendineae, papillary muscles, and left ventricle can lead to severe mitral regurgitation (MR), which can lead to left ventricular failure, pulmonary hypertension , atrial fibrillation, stroke and death. According to the latest epidemiological survey data from the United States and other western developed countries, mitral regurgitation is the type of valvular disease with the highest incidence in the elderly over 65 years old. At present, although there is no authoritative epidemiological survey data in my country, with the advent of the aging population, there is no doubt that the number of mitral valve regurgitation patients in my country is huge. Mitral regurgitation can be divided into degenerative MR and functional MR. Degenerative MR is caused by pathological changes in one or more of the valve leaflets, valve annulus, chordae tendineae and papillary muscles; functional MR is usually left ventricular function Abnormalities, such as annulus enlargement, but the mitral valve is usually normal.
目前,MR的治疗方法主要包括药物治疗、外科手术及介入治疗。药物治疗只能改善患者症状,不能延长患者生存时间。外科手术主要是瓣膜修复术或瓣膜置换术,被公认为是二尖瓣反流的首选治疗方法,已被证实能缓解患者的症状及延长其寿命。然而对于很多高龄合并多系统疾病的高危患者,手术风险高,生存获益少,根据欧洲数据显示,此类患者的外科手术成功率仅50%,重度功能性MR患者的外科手术成功率更是低至16%。因此,经导管介入二尖瓣修复及置换理论上可使失去外科手术机会的高危患者获益。介入治疗是将人工植入物在体外装载至输送系统上,沿血管路径或穿刺心尖送达二尖瓣瓣环处,然后释放并固定以完全或部分替代自体瓣膜的功能。当前,二尖瓣介入治疗已成为相关领域研究的热点之一,众多产品均在研发中。但因二尖瓣本身及周边结构复杂等问题,二尖瓣介入器械的发展面临许多特殊困难。At present, the treatment methods of MR mainly include drug therapy, surgery and interventional therapy. Drug treatment can only improve the patient's symptoms, but cannot prolong the patient's survival time. Surgery, primarily valve repair or valve replacement, is recognized as the treatment of choice for mitral regurgitation and has been shown to relieve symptoms and prolong life. However, for many elderly high-risk patients with multisystem disease, the surgical risk is high and the survival benefit is low. According to European data, the surgical success rate of such patients is only 50%, and the surgical success rate of patients with severe functional MR is even higher. as low as 16%. Therefore, transcatheter interventional mitral valve repair and replacement could theoretically benefit high-risk patients who have lost the opportunity for surgery. Interventional therapy is to load the artificial implant on the delivery system in vitro, along the vascular path or puncture the apex to deliver the mitral valve annulus, and then release and fix it to completely or partially replace the function of the native valve. At present, mitral valve interventional therapy has become one of the research hotspots in related fields, and many products are under research and development. However, due to the complex structure of the mitral valve itself and its surrounding structure, the development of mitral valve interventional devices faces many special difficulties.
专利CN201880035165.9公开了一种微创植入式装置和二尖瓣植入物系统,其包括装置(10)具有瓣环成形术环(11),其中所述瓣环成形术环(11):-具有至少一个组织锚(15);-可在递送构型(57)和打开构型(X)之间变形,在所述递送构型中,瓣环成形术环(11)被压缩到一定尺寸并插入左心房(12),在所述打开构型中,瓣环成形术环(11)扩展到其原始初始形状(58),以影响解剖开口(9),并固定在解剖开口处;-通常为环形,其具有用于稳定的内层和至少一个外部包围层,通过所述外部包围层拉出至少一根人造线(33);并且-具有圆形的环体(27),所述圆形的环体(27);-具有前部(20),其接合前叶(16)的二尖瓣环(13)的前侧(31)的组织锚位置(24),并且-具有后部(21),其接合后叶(17)的二尖瓣环(13)的后侧(32)的组织锚位置(24),其为瓣环成形术环(11)的组织锚位置(24)提供来自至少一个组织锚(15)的至少一根组织锚线(33);其中组织锚(15)可围绕二尖瓣环(13)定位,并且每个植入在二尖瓣环(13)上的组织锚(15)设有组织锚线(33),以将瓣环成形术环(11)固定到组织锚(15)。该技术方案利用“螺旋状的锚定针”将瓣环成形术环固定在二尖瓣的瓣环位置处……而随着心脏周而复始的搏动,“螺旋状的锚定针”与瓣环成形术环之间容易出现松动、导致其锚定针从瓣环成形术环上脱落的情况,从而导致植入假体失效。Patent CN201880035165.9 discloses a minimally invasive implantable device and a mitral valve implant system, comprising a device (10) having an annuloplasty ring (11), wherein the annuloplasty ring (11) :- has at least one tissue anchor (15);- is deformable between a delivery configuration (57) and an open configuration (X) in which the annuloplasty ring (11) is compressed to sized and inserted into the left atrium (12), in the open configuration, the annuloplasty ring (11) is expanded to its original initial shape (58) to impact the anatomical opening (9) and is secured at the anatomical opening ; - generally annular, having an inner layer for stabilization and at least one outer envelope through which at least one artificial thread (33) is drawn; and - having a circular ring body (27), said circular annulus (27);- having an anterior portion (20) engaging the tissue anchor position (24) of the anterior side (31) of the mitral valve annulus (13) of the anterior leaflet (16), and- Tissue anchor location (24) of the posterior side (32) of the mitral valve annulus (13) having a posterior portion (21) engaging the posterior leaflet (17), which is the tissue anchor location of the annuloplasty ring (11) (24) providing at least one tissue anchor wire (33) from at least one tissue anchor (15); wherein the tissue anchors (15) are positionable around the mitral valve annulus (13) and each implanted in the mitral valve annulus The tissue anchor (15) on (13) is provided with a tissue anchor wire (33) to secure the annuloplasty ring (11) to the tissue anchor (15). This technical solution uses a "spiral anchoring needle" to fix the annuloplasty ring at the annulus position of the mitral valve... And with the repeated beating of the heart, the "spiral anchoring needle" and the annuloplasty The rings are prone to loosening, causing the anchoring pin to fall off the annuloplasty ring, resulting in failure of the implanted prosthesis.
专利CN201910354329.0公开了一种用于减小二尖瓣环开口面积的装置,该装置包括锚定件、封堵件和连接绳,锚定件适于与二尖瓣环相连,封堵件具有两个盘体,两个盘体之间具有间隙,两个盘体分别位于房间隔的两边,以实现封堵件与房间隔相连,连接绳的两端分别于锚定件和封堵件相连通过调整锚定件与封堵件的之间的距离,以实现调整二尖瓣环的开口面积。该装置采用连接绳连接锚定件和封堵件,较为容易地实现了锚定件与封堵件之间距离的调整,较好地实现了减小了二尖瓣环开口面积的功能。与此同时,锚定件直接连接在二尖瓣环上降低了该装置对静脉的不利影响,提高该装置的使用安全性。其中,技术方案所采用的锚定件是常用的“螺旋状”或者是“双钩状”,而在假体长期植入后,由于锚定件并没有设计进一步锁定使其锚定更加牢靠的结构,心脏的搏动会使得锚 定件容易从瓣环位置处脱离。Patent CN201910354329.0 discloses a device for reducing the opening area of the mitral valve annulus. The device includes an anchoring member, a blocking member and a connecting rope. The anchoring member is adapted to be connected with the mitral valve annulus. The blocking member It has two discs, there is a gap between the two discs, and the two discs are located on both sides of the interatrial septum, so as to realize the connection between the blocking piece and the interatrial septum, and the two ends of the connecting rope are respectively connected to the anchor piece and the blocking piece. The connection is made by adjusting the distance between the anchor and the occluder, so as to adjust the opening area of the mitral valve annulus. The device uses a connecting rope to connect the anchoring piece and the blocking piece, so that the distance between the anchoring piece and the blocking piece can be adjusted easily, and the function of reducing the opening area of the mitral valve annulus is better achieved. At the same time, the direct connection of the anchoring piece on the mitral valve annulus reduces the adverse effect of the device on the vein and improves the safety of the device in use. Among them, the anchors used in the technical solution are commonly used "spiral" or "double hook", and after long-term implantation of the prosthesis, the anchors are not designed to further lock the structure to make the anchoring more reliable. , the beating of the heart can easily disengage the anchor from the annulus.
综上所述,尽管以上描述的技术方案中均采用了锚定件的方式将假体固定在患者心内,但由于锚定件并没有设计进一步锁定功能使其锚定效果更加牢靠的结构,因此在心脏不断搏动的过程中,锚定件很容易从所属的锚定区域内脱离,导致假体失去固定点。To sum up, although the anchors are used to fix the prosthesis in the patient's heart in the technical solutions described above, since the anchors are not designed with a further locking function to make the anchoring effect more reliable, Therefore, in the process of continuous beating of the heart, the anchoring piece is easily detached from the anchoring area to which it belongs, resulting in the loss of the fixation point of the prosthesis.
发明内容SUMMARY OF THE INVENTION
本发明的目的是提供一种应用在植入假体上的防脱锚定机构,该瓣膜假体具备以下优点:锚定件穿过锚定区域与心脏组织配合连接,使得支架被固定在心内,同时防脱件穿过锚定区域后最终与锚定区域连接,使得防脱锚定机构被锁定在锚定区域上,避免锚定件发生松动、从锚定区域上脱离的情况;The purpose of the present invention is to provide an anti-detachment anchoring mechanism applied to an implanted prosthesis, and the valve prosthesis has the following advantages: the anchoring member passes through the anchoring area and is connected with the cardiac tissue, so that the stent is fixed in the heart At the same time, after passing through the anchoring area, the anti-detachment piece is finally connected to the anchoring area, so that the anti-detachment anchoring mechanism is locked on the anchoring area, so as to prevent the anchoring piece from loosening and detaching from the anchoring area;
为了解决上述技术问题,本发明通过下述技术方案得以解决:一种应用在植入假体上的防脱锚定机构,包括植入假体、推送装置和设置在推送装置内的防脱锚定机构,所述防脱锚定机构包括锚定件和防脱件,所述锚定件一端和防脱件的一端连接,所述推送装置推动所述防脱锚定机构并使得所述锚定件的另一端穿过所述锚定区域并与心脏组织配合连接,进一步推动所述防脱锚定机构时,所述防脱件的另一端穿过所述锚定区域后折回并最终与所述锚定区域形成两个或多个连接点。In order to solve the above technical problems, the present invention is solved by the following technical solutions: an anti-dropping anchoring mechanism applied to an implanted prosthesis, comprising an implanted prosthesis, a pushing device and an anti-dropping anchor arranged in the pushing device An anchoring mechanism, the anti-dropping anchoring mechanism includes an anchor piece and an anti-dropping piece, one end of the anchor piece is connected with one end of the anti-dropping piece, and the pushing device pushes the anti-dropping anchoring mechanism and makes the anchor The other end of the fixing piece passes through the anchoring area and is matched with the heart tissue, and when the anti-dropping anchoring mechanism is further pushed, the other end of the anti-dropping piece passes through the anchoring area and then folds back and finally connects with the heart tissue. The anchor regions form two or more attachment points.
本发明还可以通过以下技术方案进一步实现:The present invention can also be further realized through the following technical solutions:
优选地,所述推送装置包括输送导管和推杆,所述推杆和所述防脱锚定机构被设置在所述输送导管内,所述防脱锚定机构被设置在所述推杆的远端侧,所述推杆推动所述防脱锚定机构并使得所述锚定件的另一端穿过所述锚定区域并与心脏组织配合连接,进一步推动所述防脱锚定机构时,所述防脱件的另一端穿过所述锚定区域后折回并最终与所述锚定区域形成两个或多个连接点。Preferably, the pushing device includes a delivery catheter and a push rod, the push rod and the anti-detachment anchoring mechanism are arranged in the delivery catheter, and the anti-detachment anchoring mechanism is arranged on the side of the push rod. At the distal end, the push rod pushes the anti-detachment anchoring mechanism and makes the other end of the anchor pass through the anchoring area and is connected with the heart tissue, and when the push rod further pushes the anti-detachment anchoring mechanism , the other end of the anti-falling piece passes through the anchoring area and then folds back and finally forms two or more connection points with the anchoring area.
优选地,所述锚定件的长度大于所述防脱件的长度。Preferably, the length of the anchoring member is greater than the length of the anti-falling member.
优选地,所述锚定件与所述防脱件均具有预设形状。Preferably, both the anchoring member and the anti-falling member have a predetermined shape.
优选地,所述锚定件为一个或多个弧形锚定针。Preferably, the anchors are one or more arcuate anchoring needles.
更优选地,所述锚定件可以为一个或多个螺旋状结构的锚定针。More preferably, the anchoring member may be one or more anchoring needles in a helical structure.
优选地,所述防脱件可以为一个或多个弧形锚定针。Preferably, the anti-falling element can be one or more arc-shaped anchoring needles.
更优选地,所述防脱件可以为一个或多个螺旋状结构的锚定针。More preferably, the anti-shedding member may be one or more anchoring needles in a helical structure.
更优选地,当所述锚定件为一个或多个弧形锚定针时,所述防脱件可以为一个或多个弧形锚定针。More preferably, when the anchoring member is one or more arc-shaped anchoring needles, the anti-dropping member may be one or more arc-shaped anchoring needles.
更优选地,当所述锚定件为一个或多个弧形锚定针时,所述防脱件可以为一个或多个螺旋状结构的锚定针。More preferably, when the anchoring member is one or more arc-shaped anchoring needles, the anti-dropping member may be one or more anchoring needles of helical structure.
更优选地,当所述锚定件可以为一个或多个螺旋状结构的锚定针,所述防脱件可以为一个或多个弧形锚定针。More preferably, when the anchoring member can be one or more anchoring needles of helical structure, the anti-dropping member can be one or more arc-shaped anchoring needles.
更优选地,当所述锚定件可以为一个或多个螺旋状结构的锚定针,所述防脱件可以为一个或多个螺旋状结构的锚定针。More preferably, when the anchoring member can be one or more anchoring needles with a helical structure, the anti-dropping member can be one or more anchoring needles with a helical structure.
优选地,所述锚定区域上覆膜,所述膜材料包括金属材料、聚四氟乙烯、聚乙烯、聚丙烯、涤纶或动物源性材料。Preferably, the anchoring region is covered with a film, and the film material includes metal material, polytetrafluoroethylene, polyethylene, polypropylene, polyester or animal-derived material.
优选地,所述支架还包括心房段,所述心房段被设置在所述瓣膜缝制段的远端,所述锚定区域被设置在所述心房段上。Preferably, the stent further comprises an atrial segment disposed distally of the valve suture segment, and the anchoring region is disposed on the atrial segment.
在另一个实施方式中,所述支架还包括固定装置,所述锚定区域被设置在所述固定装置上,所述固定装置一端连接在所述瓣膜缝制段的近端部分上。In another embodiment, the stent further comprises a fixation device on which the anchoring region is disposed, and one end of the fixation device is connected to the proximal end portion of the valve suture segment.
优选地,所述推杆一端与所述防脱锚定机构可拆卸连接。Preferably, one end of the push rod is detachably connected to the anti-dropping anchoring mechanism.
优选地,所述锚定件的另一端穿过锚定区域、心脏组织后与瓣膜缝制段连接。Preferably, the other end of the anchoring member is connected to the valve suture segment after passing through the anchoring region and the cardiac tissue.
更优选地,所述锚定件的另一端穿过锚定区域、心脏组织、瓣膜缝制段后并处于人工瓣膜与瓣膜缝制段之间。More preferably, the other end of the anchor passes through the anchoring region, the heart tissue, behind the valve sewing segment and is between the prosthetic valve and the valve sewing segment.
更优选地,所述防脱件的另一端穿过锚定区域、心脏组织后,最终与所述锚定区域连接。More preferably, after passing through the anchoring region and the cardiac tissue, the other end of the anti-falling element is finally connected to the anchoring region.
优选地,所述防脱锚定机构还包括限位件,所述锚定件一端和防脱件一端分别与所述限位件固定连接。Preferably, the anti-dropping anchoring mechanism further includes a limiting member, and one end of the anchoring member and one end of the anti-dropping member are respectively fixedly connected to the limiting member.
优选地,所述锚定件另一端的端部设置有倒刺结构或者所述锚定件上均布设置有微刺。Preferably, the end of the other end of the anchoring member is provided with a barb structure or the anchoring member is evenly provided with micro-thorns.
优选地,所述防脱件另一端的端部设置有倒刺结构或者所述防脱件上均布设置有微刺。Preferably, the end of the other end of the anti-dropping member is provided with a barb structure or the anti-dropping member is evenly provided with micro-thorns.
与现有技术相比,本发明的优点在于:Compared with the prior art, the advantages of the present invention are:
1.本发明中的锚定件穿过锚定区域与心脏组织配合连接,使得支架被固定在心内,同时防脱件穿过锚定区域后最终与锚定区域形成2个连接点;区别于现有技术中锚定件与锚定区域始终只有一个 连接点,使得锚定件在锚定区域上只有一个受力点,当支架受到血流冲击时,锚定件很容易从锚定区域中脱出,从而导致支架失去固定点,而本发明的防脱件在锚定区域上具备2个或多个受力点,使得支架在到血流冲击时,防脱件能将冲击力分散/化解到2个或多个受力点上,从而减少锚定件的受力,使得防脱锚定机构被锁定在锚定区域上,避免锚定件相对锚定区域发生松动、从锚定区域上脱离的情况;1. The anchoring member in the present invention is connected with the heart tissue through the anchoring area, so that the stent is fixed in the heart, and at the same time, after the anti-dropping member passes through the anchoring area, it finally forms two connection points with the anchoring area; In the prior art, there is always only one connection point between the anchor and the anchor area, so that the anchor has only one point of force on the anchor area. When the stent is impacted by blood flow, the anchor can easily escape from the anchor area. Therefore, the stent loses its fixed point, and the anti-detachment member of the present invention has two or more stress points on the anchoring area, so that when the stent is impacted by blood flow, the anti-detachment member can disperse/dissolve the impact force. to 2 or more stress points, thereby reducing the stress of the anchor, so that the anti-drop anchor mechanism is locked on the anchor area, preventing the anchor from loosening relative to the anchor area and from the anchor area. disengagement;
2.本发明中的主锁定件的长度大于辅助锁定件的长度,这样设计的好处在于:被用于二尖瓣瓣膜疾病治疗时,主锁定件将支架与组织固定,防脱件穿过锚定区域又最终与锚定区域连接使得防脱锚定机构被锁定在锚定区域上,且辅助锁定件的长度较短,因此在锚定/锁定的过程中不会勾住或者压迫神经束、冠状静脉窦等心脏组织,避免对心内组织发生损伤或者撕裂的情况;同时,更短的防脱件力矩更小,更不容易变形、拉脱,可以使得防脱锚定机构与锚定区域的锁定更加稳固;2. The length of the main locking piece in the present invention is greater than the length of the auxiliary locking piece. The advantage of this design is that: when it is used for the treatment of mitral valve disease, the main locking piece fixes the stent and the tissue, and the anti-dropping piece passes through the anchor. The anchoring area is finally connected with the anchoring area, so that the anti-detachment anchoring mechanism is locked on the anchoring area, and the length of the auxiliary locking member is short, so it will not hook or compress the nerve bundle during the anchoring/locking process. Coronary venous sinus and other cardiac tissues, avoiding damage or tearing of intracardiac tissues; at the same time, the shorter anti-dropping parts have smaller torque, and are less prone to deformation and pull-off, which can make the anti-dropping anchoring mechanism and anchoring The locking of the area is more stable;
3.本发明中的推杆一端与防脱锚定机构为可拆卸连接,当推杆将防脱锚定机构推送并锚定到目标位置后,推杆能撤离出人体,极大的减少了植入物,减少对心房的接触和刺激,方便输送系统撤离人体;3. One end of the push rod in the present invention is detachably connected to the anti-dropping anchoring mechanism. When the push rod pushes and anchors the anti-dropping anchoring mechanism to the target position, the push rod can be evacuated from the human body, which greatly reduces the Implants that reduce contact and stimulation of the atrium and facilitate the evacuation of the delivery system from the body;
4.本发明中锚定件穿过锚定区域、穿过心脏组织并与瓣膜缝制段连接,这样设计的目的在于:锚定件的两端都与支架连接,使得二者之间被联成一个整体,在锚定件被植入后相对支架之间不容易发生松动,避免其锚定件从锚定区域拉脱/脱离的情况;4. In the present invention, the anchoring piece passes through the anchoring area, passes through the heart tissue and is connected with the valve suture segment. The purpose of this design is: both ends of the anchoring piece are connected with the stent, so that the two are connected to each other. As a whole, it is not easy to loosen between the relative stents after the anchors are implanted, so as to avoid the pull-off/detachment of the anchors from the anchoring area;
5.本发明中辅助锁定件穿过锚定区域、心脏组织后最终与锚定区域连接,这样设计的好处在于:防脱件需要穿过心脏组织后最终与锚定区域连接,使得防脱件锁定在锚定区域的同时又与部分心脏组织连接在一起,进一步巩固了防脱件的锚定效果;5. In the present invention, the auxiliary locking member is finally connected to the anchoring area after passing through the anchoring area and the heart tissue. The advantage of this design is that the anti-dropping member needs to pass through the heart tissue and finally connect to the anchoring area, so that the anti-dropping member needs to pass through the heart tissue and finally connect to the anchoring area. While locked in the anchoring area, it is connected with part of the heart tissue, further consolidating the anchoring effect of the anti-dropping piece;
6.本发明中锚定件的另一端与防脱件的另一端均设置有倒刺结构或者锚定件和防脱件上均布设有微刺结构,这样设计的好处在于,能进一步增加防脱锚定机构的锚定效果,更有效的避免防脱锚定机构从锚定区域内拉脱/脱离的情况。6. In the present invention, the other end of the anchoring piece and the other end of the anti-dropping piece are both provided with a barb structure or the anchoring piece and the other end of the anti-dropping piece are evenly provided with a micro-thorn structure. The anchoring effect of the de-anchoring mechanism can more effectively avoid the pull-off/detachment of the anti-detachment anchoring mechanism from the anchoring area.
附图说明Description of drawings
图1a~1b为本发明的整体结构示意图。1a-1b are schematic diagrams of the overall structure of the present invention.
图2a~2e为防脱锚定机构植入锚定的过程示意图。Figures 2a-2e are schematic diagrams of the process of implanting the anchorage by the anti-dropping anchoring mechanism.
图3a~3b为锚定件在锚定区段形成连接点的结构示意图。Figures 3a-3b are schematic diagrams of the structure of the anchoring member forming the connection point in the anchoring section.
图4a~4m为防脱锚定机构多种实施方式的结构示意图。4a-4m are schematic structural diagrams of various embodiments of the anti-dropping anchoring mechanism.
图5a~5c为防脱锚定机构与心脏组织连接的多种结构示意图。5a-5c are schematic diagrams of various structures of the connection between the anti-dropping anchoring mechanism and the cardiac tissue.
图6a~6b为防脱锚定机构另一种实施方式的结构示意图。6a-6b are schematic structural diagrams of another embodiment of the anti-dropping anchoring mechanism.
图7a~7e为另一实施例的过程示意图。7a-7e are schematic process diagrams of another embodiment.
附图中各数字所指代的部位名称如下:1-支架,11-瓣膜缝制段,12-心房段,13-锚定区域,2-防脱锚定机构,21-锚定件,22-防脱件,3-防脱锚定机构推送装置,31-输送导管,32-推杆,4-限位件,5-倒刺结构,6-微刺,7-固定装置。The names of the parts referred to by the numbers in the drawings are as follows: 1-Stent, 11-Valve suture segment, 12-Atrial segment, 13-Anchoring area, 2-Anchoring mechanism for anti-shedding, 21-Anchoring piece, 22 -Anti-detachment piece, 3-Anchoring mechanism pushing device, 31-Delivery catheter, 32-Push rod, 4-Limiting piece, 5-Barb structure, 6-Micro-thorn, 7-Fixing device.
具体实施方式detailed description
下面结合附图与实施例对本发明作进一步详细描述。The present invention will be described in further detail below with reference to the accompanying drawings and embodiments.
本发明所述的近端是指接近心尖的一端,所述的远端是指远离心尖的一端。In the present invention, the proximal end refers to the end close to the apex of the heart, and the distal end refers to the end away from the apex of the heart.
具体实施例一:Specific embodiment one:
在用于二尖瓣瓣膜疾病治疗时,如图1a和图1b所示,一种应用在植入假体上的防脱锚定机构,包括瓣膜假体1、推送装置3和设置在推送装置3内的防脱锚定机构2,所述瓣膜假体1包括瓣膜缝制段11心房段12和锚定区域13,所述心房段12被设置在所述瓣膜缝制段11的远端,所述锚定区域13被设置在所述心房段12上,所述锚定区域13上设置有防脱锚定机构2,所述防脱锚定机构2包括锚定件21和防脱件22,所述锚定件21一端和防脱件22一端固定连接,如图2a~图2e所示,位于所述输送导管31中的所述推杆32推动所述防脱锚定机构2并使得所述锚定件21的另一端穿过锚定区域13与心脏组织配合连接,进一步推动所述防脱锚定机构2;如图3a所示,所述防脱件22的另一端穿过所述锚定区域13后折回并最终与所述锚定区域13形成两个连接点,防脱件22限制所述锚定件21脱离所述锚定区域13;锚定件21穿过锚定区域13与心脏组织配合连接,使得支架1被固定在心内,同时防脱件22穿过锚定区域13后最终与锚定区域13连接,使得防脱锚定机构2被锁定在锚定区域13上,避免锚定件21相对锚定区域13发生松动、从锚定区域13上脱离的情况。When used for the treatment of mitral valve disease, as shown in Fig. 1a and Fig. 1b, an anti-detachment anchoring mechanism applied to an implanted prosthesis includes a valve prosthesis 1, a pushing device 3, and a pushing device disposed on the pushing device The anti-detachment anchoring mechanism 2 in 3, the valve prosthesis 1 comprises a valve sewing segment 11 atrial segment 12 and an anchoring region 13, the atrial segment 12 is arranged at the distal end of the valve sewing segment 11, The anchoring region 13 is arranged on the atrium segment 12 , and the anchoring region 13 is provided with an anti-dropping anchoring mechanism 2 , and the anti-dropping anchoring mechanism 2 includes an anchoring member 21 and a falling-off preventing member 22 . , one end of the anchoring member 21 is fixedly connected with one end of the anti-dropping member 22 , as shown in FIGS. 2 a to 2 e , the push rod 32 located in the delivery catheter 31 pushes the anti-dropping anchoring mechanism 2 and makes the The other end of the anchoring member 21 passes through the anchoring area 13 and is connected to the cardiac tissue, and further pushes the anti-dropping anchoring mechanism 2; as shown in FIG. 3a, the other end of the anti-dropping member 22 passes through the The anchoring area 13 is folded back and finally forms two connection points with the anchoring area 13. The anti-dropping member 22 restricts the anchoring member 21 from leaving the anchoring area 13; the anchoring member 21 passes through the anchoring area. 13 is matched and connected with the heart tissue, so that the stent 1 is fixed in the heart, and the anti-detachment member 22 is finally connected to the anchoring area 13 after passing through the anchoring area 13, so that the anti-detachment anchoring mechanism 2 is locked on the anchoring area 13. , to avoid the situation in which the anchor 21 is loosened relative to the anchor area 13 and detached from the anchor area 13 .
下面将结合附图详细描述本发明的可逆调弯的瓣膜输送系统各部件的组成和连接方式;The composition and connection mode of each component of the reversibly adjustable valve delivery system of the present invention will be described in detail below with reference to the accompanying drawings;
本实施例中,如图1b所示,所述瓣膜假体还包括推送装置3,所述推送装置3包括输送导管31和推杆32,所述推杆32和所述防脱锚定机构2被设置在所述输送导管31内,所述防脱锚定机构2被设置在所述推杆32的远端侧,当所述推杆32推动所述防脱锚定机构2时,所述锚定件21的另一端穿过锚定区域13与心脏组织配合连接,进一步推动所述推杆32时,所述防脱件22的另一端穿过所述锚定区域13最终与所述锚定区域13配合连接,防脱件22限制所述锚定件21脱离所述锚定区域13。In this embodiment, as shown in FIG. 1b, the valve prosthesis further includes a pushing device 3, the pushing device 3 includes a delivery catheter 31 and a push rod 32, the push rod 32 and the anti-drop anchoring mechanism 2 Set in the delivery catheter 31, the anti-detachment anchoring mechanism 2 is set on the distal end side of the push rod 32. When the push rod 32 pushes the anti-detachment anchoring mechanism 2, the The other end of the anchoring member 21 passes through the anchoring area 13 and is connected with the heart tissue. When the push rod 32 is pushed further, the other end of the anti-dropping member 22 passes through the anchoring area 13 and finally connects with the anchor. The anchoring area 13 is matched and connected, and the disengagement prevention member 22 restricts the anchoring member 21 from being separated from the anchoring area 13 .
在另一个优选实施例中,所述推送装置3推动所述防脱锚定机构2并使得所述锚定件21的另一端穿过锚定区域13与心脏组织配合连接,进一步推动所述防脱锚定机构2时;如图3b所示,所述防脱件22的另一端穿过所述锚定区域13后折回并最终与所述锚定区域13形成三个连接点,防脱件22限制所述锚定件21脱离所述锚定区域13。In another preferred embodiment, the pushing device 3 pushes the anti-detachment anchoring mechanism 2 and makes the other end of the anchoring piece 21 pass through the anchoring area 13 to be connected with the cardiac tissue, and further push the anti-detachment anchoring mechanism 2 . When the anchoring mechanism 2 is disengaged; as shown in FIG. 3b, the other end of the disengagement prevention member 22 passes through the anchoring area 13 and then folds back to form three connection points with the anchoring area 13. 22 restricts the anchoring member 21 from disengaging from the anchoring region 13 .
本实施例中,所述锚定区域13上覆膜,所述膜材料包括金属材料、聚四氟乙烯、聚乙烯、聚丙烯、涤纶或动物源性材料。In this embodiment, the anchoring region 13 is covered with a film, and the film material includes metal material, polytetrafluoroethylene, polyethylene, polypropylene, polyester, or animal-derived material.
本实施例中,所述锚定件21的长度大于所述防脱件22的长度;这样设计的好处在于:主锁定件将支架1与组织固定,防脱件22穿过锚定区域13又最终与锚定区域13连接使得防脱锚定机构2被锁定在锚定区域13上,且辅助锁定件的长度较短,因此在锚定/锁定的过程中不会勾住或者压迫神经束、冠状静脉窦等心脏组织,避免对心内组织发生损伤或者撕裂的情况;同时,更短的防脱件22力矩更小,更不容易变形、拉脱,可以使得防脱锚定机构2与锚定区域13的锁定更加稳固。In this embodiment, the length of the anchoring member 21 is greater than the length of the anti-dropping member 22 ; the advantage of this design is that the main locking member fixes the stent 1 and the tissue, and the anti-dropping member 22 passes through the anchoring area 13 and Finally, it is connected with the anchoring area 13 so that the anti-dropping anchoring mechanism 2 is locked on the anchoring area 13, and the length of the auxiliary locking member is short, so it will not hook or compress the nerve bundle during the anchoring/locking process, Coronary venous sinus and other cardiac tissues can avoid damage or tearing of intracardiac tissues; at the same time, the shorter anti-dropping member 22 has a smaller torque and is less prone to deformation and pull-off, which can make the anti-dropping anchoring mechanism 2 and the The locking of the anchoring area 13 is more secure.
本实施例中,所述锚定件21的另一端的形态可以是螺旋状结构;同样地,所述防脱件22的另一端的形态也可以是螺旋状结构,如图4a所示,当所述防脱件22的另一端的形态是螺旋状结构时,所述防脱件22与锚定区域会形成4个连接点,进一步确保防脱件22不会从锚定区域13上脱离,进而保证使得瓣膜假体1在到血流冲击时,防脱件22能将冲击力分散/化解到这4个受力点上,从而减少锚定件21的受力,使得防脱锚定机构2被锁定在锚定区域上13,避免锚定件21相对锚定区域13发生松动、从锚定区域13上脱离的情况。In this embodiment, the shape of the other end of the anchoring member 21 may be a spiral structure; similarly, the shape of the other end of the anti-dropping member 22 may also be a spiral structure, as shown in FIG. 4a , when When the shape of the other end of the anti-dropping member 22 is a helical structure, the anti-dropping member 22 and the anchoring area will form four connection points to further ensure that the anti-dropping member 22 will not be detached from the anchoring area 13. In this way, it is ensured that when the valve prosthesis 1 is impacted by blood flow, the anti-detachment member 22 can disperse/dissolve the impact force to these four stress points, thereby reducing the force of the anchoring member 21 and making the anti-detachment anchoring mechanism 2 is locked on the anchoring area 13 to prevent the anchoring piece 21 from loosening relative to the anchoring area 13 and detaching from the anchoring area 13 .
在另一种实施方式中,所述防脱件22的另一端可设置有多个尖锐部,如图4b所示,防脱件22的另一端穿过所述锚定区域13后折回并最终与所述锚定区域13形成多个连接点。In another embodiment, the other end of the anti-dropping member 22 may be provided with a plurality of sharp parts, as shown in FIG. 4b , the other end of the anti-dropping member 22 passes through the anchoring area 13 and then is folded back and finally A plurality of connection points are formed with the anchoring region 13 .
在另一种实施方式中,所述防脱锚定机构2还设置有连接段,如图4c所示,所述连接段呈弧形结构设置,所述锚定件21的一端与所述连接段连接,所述防脱件22的一端与所述连接段连接。In another embodiment, the anti-detachment anchoring mechanism 2 is further provided with a connecting section, as shown in FIG. 4c , the connecting section is arranged in an arc structure, and one end of the anchoring member 21 is connected to the connecting section. A segment is connected, and one end of the anti-falling member 22 is connected with the connection segment.
本实施例中,如图4d和4e所示,所述锚定件21与所述防脱件22均具有预设形状;当所述锚定件21为一个或多个弧形锚定针时,所述防脱件22可以为一个或多个弧形锚定针。In this embodiment, as shown in Figures 4d and 4e, both the anchoring member 21 and the anti-dropping member 22 have a preset shape; when the anchoring member 21 is one or more arc-shaped anchoring needles , the anti-dropping member 22 can be one or more arc-shaped anchoring needles.
在另一种实施方式中,如图4f所示,当所述锚定件21为一个或多个弧形锚定针时,所述防脱件22可以为一个或多个螺旋状结构的锚定针。In another embodiment, as shown in FIG. 4f , when the anchoring member 21 is one or more arc-shaped anchoring needles, the anti-dropping member 22 can be one or more anchors of helical structure Fixed needle.
在另一种实施方式中,如图4g所示,当所述锚定件21可以为一个或多个螺旋状结构的锚定针,所述防脱件22可以为一个或多个弧形锚定针。In another embodiment, as shown in FIG. 4g , when the anchoring member 21 can be one or more anchoring needles of helical structure, the anti-dropping member 22 can be one or more arc-shaped anchors Fixed needle.
在另一种实施方式中,如图4h和4i所示,当所述锚定件21可以为一个或多个螺旋状结构的锚定针,所述防脱件22可以为一个或多个螺旋状结构的锚定针。In another embodiment, as shown in Figures 4h and 4i, when the anchoring member 21 can be one or more anchoring needles in helical structure, the anti-dropping member 22 can be one or more helical structures Anchoring needle of the like structure.
在另一种实施方式中,所述防脱锚定机构2还包括限位件4,如图4j~4m所示,所述锚定件21一端和防脱件22一端分别与所述限位件4固定连接。In another embodiment, the anti-dropping anchoring mechanism 2 further includes a limiting member 4. As shown in Figures 4j to 4m, one end of the anchoring member 21 and one end of the anti-dropping member 22 are respectively connected to the limiting member 4. Piece 4 is fixedly connected.
本实施例中,所述推杆32一端与所述防脱锚定机构2可拆卸连接;具体地,所述推杆32一端与所述限位件4为活动连接(连接方式可采取公知技术,例如绳套,活结等),当确认所述防脱锚定机构2的锚定效果理想后,拆除上述活动连接,即可将所述推送装置3(包括所述输送导管31和所述推杆32)撤出人体,这样设计的好处在于能够减少植入物体积,降低血栓形成风险。In this embodiment, one end of the push rod 32 is detachably connected to the anti-detachment anchoring mechanism 2 ; specifically, one end of the push rod 32 is movably connected to the limiting member 4 (the connection method can adopt a known technology , such as rope sets, slip knots, etc.), after confirming that the anchoring effect of the anti-fall anchoring mechanism 2 is ideal, remove the above-mentioned movable connection, and then the pushing device 3 (including the delivery catheter 31 and the pushing The rod 32) is withdrawn from the human body, and the advantage of this design is that it can reduce the volume of the implant and reduce the risk of thrombosis.
本实施例中,如图5c所示,所述锚定件21的另一端穿过锚定区域13、心脏组织后与瓣膜缝制段11连接;更优选地,所述锚定件21的另一端穿过锚定区域13、心脏组织、瓣膜缝制段11后并处于人工瓣膜(未显示)与瓣膜缝制段11之间;这样设计的目的在于:锚定件21的两端都与支架1连接,使得二者之间被联成一个整体,在锚定件21被植入后相对支架1之间不容易发生松动,避免其锚定件21从锚定区域13拉脱/脱离的情况。In this embodiment, as shown in FIG. 5c , the other end of the anchoring member 21 is connected to the valve sewing segment 11 after passing through the anchoring region 13 and the heart tissue; more preferably, the other end of the anchoring member 21 is One end passes through the anchoring region 13, the heart tissue, and the valve sewing segment 11 and is between the prosthetic valve (not shown) and the valve sewing segment 11; the purpose of this design is that both ends of the anchoring member 21 are connected to the stent. 1 is connected, so that the two are connected as a whole, and the relative stent 1 is not easily loosened after the anchor 21 is implanted, so as to avoid the situation that the anchor 21 is pulled/detached from the anchor area 13 .
本实施例中,如图5a所示,所述防脱件22的另一端穿过锚定区域13、心脏组织后,最终与所述锚定区域13连接;这样设计的好处在于:防脱件22需要穿过心脏组织后最终与锚定区域13连接,使得防脱件22锁定在锚定区域13的同时又与部分心脏组织连接在一起,进一步巩固了防脱件22的 锚定效果;同理,如图5b所示,可以使其锚定件21的另一端穿过锚定区域13、心脏组织、瓣膜缝制段11后并处于人工瓣膜(未显示)与瓣膜缝制段11之间,以及防脱件22的另一端穿过锚定区域13、心脏组织后,最终与所述锚定区域13连接。In this embodiment, as shown in FIG. 5a, after the other end of the anti-dropping member 22 passes through the anchoring region 13 and the heart tissue, it is finally connected to the anchoring region 13; the advantages of this design are: 22 needs to be finally connected to the anchoring area 13 after passing through the heart tissue, so that the anti-shedding member 22 is locked in the anchoring area 13 and connected with part of the heart tissue, further consolidating the anchoring effect of the anti-falling member 22; the same As shown in FIG. 5b, the other end of the anchoring member 21 can be passed through the anchoring region 13, the heart tissue, behind the valve sewing segment 11 and between the prosthetic valve (not shown) and the valve sewing segment 11. , and the other end of the anti-dropping member 22 is finally connected to the anchoring region 13 after passing through the anchoring region 13 and the cardiac tissue.
本实施例中,如图6a所示,所述锚定件21另一端的端部设置有倒刺结构5或者所述锚定件21上均布设置有微刺6;能进一步增加锚定件21的锚定效果,更有效的避免锚定件21从锚定区域13内拉脱/脱离的情况。In this embodiment, as shown in Fig. 6a, the other end of the anchoring member 21 is provided with a barb structure 5 or the anchoring member 21 is evenly provided with micro-thorns 6; the anchoring member can be further increased The anchoring effect of 21 can more effectively avoid the pull-off/detachment of the anchoring member 21 from the anchoring area 13 .
本实施例中,如图6b所示,所述防脱件22另一端的端部设置有倒刺结构5或者所述防脱件22上均布设置有微刺6;这样设计的好处在于:能进一步增加防脱件22的的锁定效果,更有效的避免锚定件21从锚定区域13内拉脱/脱离的情况。In this embodiment, as shown in Fig. 6b, the end of the other end of the anti-dropping member 22 is provided with a barb structure 5 or the anti-dropping member 22 is evenly provided with micro-thorns 6; the advantages of this design are: The locking effect of the anti-releasing member 22 can be further increased, and the situation that the anchoring member 21 is pulled/detached from the anchoring area 13 is more effectively avoided.
具体实施例二:Specific embodiment two:
在用于三尖瓣瓣膜疾病治疗时,如图7a~7e所示,一种应用在植入假体上的防脱锚定机构,包括支架1和人工瓣膜(未显示),所述支架1包括瓣膜缝制段11、固定装置7和锚定区域13,所述锚定区域13被设置在所述固定装置7上,所述锚定区域13上设置有防脱锚定机构2,所述固定装置7一端连接在所述瓣膜缝制段11的近端部分上,所述固定装置7的另一端贴近患者的室间隔位置,所述固定装置7通过所述防脱锚定机构2固定在患者室间隔上并限制其瓣膜假体轴向移动,所述防脱锚定机构2包括锚定件21和防脱件22,所述锚定件21一端和防脱件22一端固定连接,所述锚定件21的另一端穿过锚定区域13与心脏组织配合连接,所述防脱件22的另一端穿过所述锚定区域13后折回并最终与所述锚定区域13形成两个连接点,防脱件22限制所述锚定件21脱离所述锚定区域13;锚定件21穿过锚定区域13与心脏组织配合连接,使得支架1被固定在心内,同时防脱件22穿过锚定区域13后最终与锚定区域13连接,使得防脱锚定机构2被锁定在锚定区域13上,避免锚定件21相对锚定区域13发生松动、从锚定区域13上脱离的情况。When used for the treatment of tricuspid valve disease, as shown in Figs. 7a to 7e, an anti-detachment anchoring mechanism applied to an implanted prosthesis includes a stent 1 and a prosthetic valve (not shown), the stent 1 It includes a valve sewing segment 11, a fixing device 7 and an anchoring area 13, the anchoring area 13 is set on the fixing device 7, and the anchoring area 13 is provided with an anti-detachment anchoring mechanism 2, the One end of the fixation device 7 is connected to the proximal end portion of the valve sewing segment 11 , and the other end of the fixation device 7 is close to the patient's ventricular septum. The valve prosthesis is placed on the patient's ventricular septum and the axial movement of the valve prosthesis is restricted. The other end of the anchoring member 21 passes through the anchoring area 13 and is connected with the heart tissue, and the other end of the anti-dropping member 22 passes through the anchoring area 13 and then is folded back and finally forms two parts with the anchoring area 13 . The anchoring member 22 restricts the anchoring member 21 from being separated from the anchoring area 13; the anchoring member 21 is connected to the heart tissue through the anchoring area 13, so that the stent 1 is fixed in the heart, while preventing from falling off. After passing through the anchoring area 13, the component 22 is finally connected to the anchoring area 13, so that the anti-dropping anchoring mechanism 2 is locked on the anchoring area 13, so as to prevent the anchoring component 21 from loosening relative to the anchoring area 13 and removing the anchoring area from the anchoring area 13. 13 on the case of disengagement.
本实施例中,所述瓣膜假体还包括推送装置3,所述推送装置3包括输送导管31和推杆32,所述推杆32和所述防脱锚定机构2被设置在所述输送导管31内,当所述推杆32推动所述防脱锚定机构2时,所述锚定件21的另一端穿过锚定区域13与心脏组织配合连接,进一步推动所述推杆32时,所述防脱件22的另一端穿过所述锚定区域13最终与所述锚定区域13配合连接,防脱件22限制所述锚定件21脱离所述锚定区域13。In this embodiment, the valve prosthesis further includes a pushing device 3, and the pushing device 3 includes a delivery catheter 31 and a push rod 32, and the push rod 32 and the anti-detachment anchoring mechanism 2 are provided in the delivery In the catheter 31 , when the push rod 32 pushes the anti-detachment anchoring mechanism 2 , the other end of the anchor 21 passes through the anchoring area 13 and is connected with the cardiac tissue, and when the push rod 32 is further pushed , the other end of the anti-dropping member 22 passes through the anchoring area 13 and is finally connected with the anchoring area 13 , and the anti-dropping member 22 restricts the anchoring member 21 from being separated from the anchoring area 13 .
本实施例中,所述锚定件21的长度大于所述防脱件22的长度;这样设计的好处在于:主锁定件将支架1与组织固定,防脱件22穿过锚定区域13又最终与锚定区域13连接使得防脱锚定机构2被锁定在锚定区域13上,且辅助锁定件的长度较短,因此在锚定/锁定的过程中不会影响其他心脏组织,避免对心内组织发生损伤或者撕裂的情况;同时,更短的防脱件22力矩更小,更不容易变形、拉脱,可以使得防脱锚定机构2与锚定区域13的锁定更加稳固。In this embodiment, the length of the anchoring member 21 is greater than the length of the anti-dropping member 22 ; the advantage of this design is that the main locking member fixes the stent 1 and the tissue, and the anti-dropping member 22 passes through the anchoring area 13 and The final connection with the anchoring area 13 makes the anti-detachment anchoring mechanism 2 locked on the anchoring area 13, and the length of the auxiliary locking piece is short, so it will not affect other cardiac tissues during the anchoring/locking process, avoiding the need for The intracardiac tissue is damaged or torn; at the same time, the shorter anti-dropping member 22 has a smaller torque and is less likely to be deformed and pulled off, which can make the locking of the anti-dropping anchoring mechanism 2 and the anchoring region 13 more stable.
本实施例中,所述锚定件21与所述防脱件22均具有预设形状;当所述锚定件21为一个或多个弧形锚定针时,所述防脱件22可以为一个或多个弧形锚定针。In this embodiment, both the anchoring member 21 and the anti-dropping member 22 have preset shapes; when the anchoring member 21 is one or more arc-shaped anchoring needles, the anti-dropping member 22 can be Anchor pins for one or more arcs.
在另一种实施方式中,当所述锚定件21为一个或多个弧形锚定针时,所述防脱件22可以为一个或多个螺旋状结构的锚定针。In another embodiment, when the anchoring member 21 is one or more arc-shaped anchoring needles, the anti-dropping member 22 can be one or more anchoring needles of helical structure.
在另一种实施方式中,当所述锚定件21可以为一个或多个螺旋状结构的锚定针,所述防脱件22可以为一个或多个弧形锚定针。In another embodiment, when the anchoring member 21 can be one or more anchoring needles of helical structure, the anti-dropping member 22 can be one or more arc-shaped anchoring needles.
在另一种实施方式中,当所述锚定件21可以为一个或多个螺旋状结构的锚定针,所述防脱件22可以为一个或多个螺旋状结构的锚定针。In another embodiment, when the anchoring member 21 can be one or more anchoring needles with a helical structure, the anti-dropping member 22 can be one or more anchoring needles with a helical structure.
本实施例中,所述防脱锚定机构2还包括限位件4,所述锚定件21一端和防脱件22一端分别与所述限位件4固定连接。In this embodiment, the anti-dropping anchoring mechanism 2 further includes a limiting member 4 , and one end of the anchoring member 21 and one end of the anti-dropping member 22 are respectively fixedly connected to the limiting member 4 .
本实施例中,所述推杆32一端与所述防脱锚定机构2可拆卸连接;具体地,所述推杆32一端与所述限位件4为活动连接(连接方式可采取公知技术,例如绳套,活结等),当确认所述防脱锚定机构2的锚定效果理想后,拆除上述活动连接,即可将所述推送装置3(包括所述输送导管31和所述推杆32)撤出人体,这样设计的好处在于能够减少植入物体积,降低血栓形成风险。In this embodiment, one end of the push rod 32 is detachably connected to the anti-detachment anchoring mechanism 2 ; specifically, one end of the push rod 32 is movably connected to the limiting member 4 (the connection method can adopt a known technology , such as rope sets, slip knots, etc.), after confirming that the anchoring effect of the anti-fall anchoring mechanism 2 is ideal, remove the above-mentioned movable connection, and then the pushing device 3 (including the delivery catheter 31 and the pushing The rod 32) is withdrawn from the human body, and the advantage of this design is that it can reduce the volume of the implant and reduce the risk of thrombosis.
本实施例中,所述锚定件21另一端的端部设置有倒刺结构5或者所述锚定件21上均布设置有微刺6;能进一步增加锚定件21的锚定效果,更有效的避免锚定件21从锚定区域13内拉脱/脱离的情况。In this embodiment, the end of the other end of the anchoring member 21 is provided with a barb structure 5 or the anchoring member 21 is evenly provided with micro-thorns 6; the anchoring effect of the anchoring member 21 can be further increased, It is more effective to avoid the pull-off/detachment of the anchoring member 21 from the anchoring region 13 .
本实施例中,所述防脱件22另一端的端部设置有倒刺结构5或者所述防脱件22上均布设置有微 刺6;这样设计的好处在于:能进一步增加防脱件22的的锁定效果,更有效的避免锚定件21从锚定区域13内拉脱/脱离的情况。In this embodiment, the end of the other end of the anti-dropping member 22 is provided with a barb structure 5 or the anti-dropping member 22 is evenly provided with micro-thorns 6; the advantage of this design is that the anti-dropping member can be further increased. The locking effect of 22 can more effectively avoid the pull-off/detachment of the anchoring member 21 from the anchoring area 13 .
需要注意的是,本发明的防脱锚定机构不仅可应用在心脏瓣膜假体领域,还可应用在其他一些需要锚定机构/锚定装置的植入假体上;例如在用于封堵心脏或血管内缺的封堵器,防脱锚定机构可锚定在封堵器的封头上,使其封堵器能更贴合心脏组织,进一步改善封堵器的封堵效果。It should be noted that the anti-detachment anchoring mechanism of the present invention can be applied not only in the field of heart valve prostheses, but also in some other implanted prostheses that require anchoring mechanisms/anchoring devices; for example, in the field of occlusion For the occluder lacking in the heart or blood vessel, the anti-detachment anchoring mechanism can be anchored on the head of the occluder, so that the occluder can better fit the heart tissue and further improve the occlusion effect of the occluder.
以上内容仅为本发明的较佳实施例,对于本领域的普通技术人员,依据本发明的思想,在具体实施方式及应用范围上均会有改变之处,本说明书内容不应理解为对本发明的限制。The above contents are only preferred embodiments of the present invention. For those of ordinary skill in the art, according to the idea of the present invention, there will be changes in the specific embodiments and application scope. limits.

Claims (10)

  1. 一种应用在植入假体上的防脱锚定机构,包括:植入假体、设置在植入假体上的锚定区域、推送装置和设置在推送装置内的防脱锚定机构,所述防脱锚定机构包括锚定件和防脱件,所述锚定件一端和防脱件的一端连接,所述推送装置推动所述防脱锚定机构并使得所述锚定件的另一端穿过所述锚定区域并与心脏组织配合连接,进一步推动所述防脱锚定机构时,所述防脱件的另一端穿过所述锚定区域后折回并最终与所述锚定区域形成两个或多个连接点。An anti-dropping anchoring mechanism applied to an implanted prosthesis, comprising: an implanted prosthesis, an anchoring area arranged on the implanted prosthesis, a pushing device, and an anti-dropping anchoring mechanism arranged in the pushing device, The anti-dropping anchoring mechanism includes an anchoring piece and an anti-dropping piece, one end of the anchoring piece is connected with one end of the anti-dropping piece, and the pushing device pushes the anti-dropping anchoring mechanism and makes the anchoring piece move. The other end passes through the anchoring area and is matched with the heart tissue. When the anti-dropping anchoring mechanism is further pushed, the other end of the anti-dropping piece passes through the anchoring area and then folds back and finally connects with the anchor. A certain area forms two or more connection points.
  2. 根据权利要求1所述的一种应用在植入假体上的防脱锚定机构,其中,所述推送装置包括输送导管和推杆,所述推杆和所述防脱锚定机构被设置在所述输送导管内,所述防脱锚定机构被设置在所述推杆的远端侧。The anti-detachment anchoring mechanism applied to an implanted prosthesis according to claim 1, wherein the pushing device comprises a delivery catheter and a push rod, and the push rod and the anti-detachment anchoring mechanism are provided Within the delivery catheter, the anti-detachment anchoring mechanism is provided on the distal side of the push rod.
  3. 根据权利要求1所述的一种应用在植入假体上的防脱锚定机构,其中,所述锚定件的长度大于所述防脱件的长度。The anti-dropping anchoring mechanism applied to an implanted prosthesis according to claim 1, wherein the length of the anchoring member is greater than the length of the anti-dropping member.
  4. 根据权利要求1所述的一种应用在植入假体上的防脱锚定机构,其中,所述锚定件为一个或多个弧形锚定针,所述防脱件为一个或多个弧形锚定针。The anti-dropping anchoring mechanism applied to an implanted prosthesis according to claim 1, wherein the anchoring member is one or more arc-shaped anchoring needles, and the anti-dropping member is one or more Arc Anchoring Needle.
  5. 根据权利要求1所述的一种应用在植入假体上的防脱锚定机构,其中,所述锚定区域上覆膜。The anti-detachment anchoring mechanism applied to an implanted prosthesis according to claim 1, wherein the anchoring region is covered with a membrane.
  6. 根据权利要求2所述的一种应用在植入假体上的防脱锚定机构,其中,所述推杆一端与所述防脱锚定机构可拆卸连接。The anti-dropping anchoring mechanism applied to an implanted prosthesis according to claim 2, wherein one end of the push rod is detachably connected to the anti-dropping anchoring mechanism.
  7. 根据权利要求1所述的一种应用在植入假体上的防脱锚定机构,其中,所述锚定件的另一端穿过锚定区域、心脏组织后与瓣膜缝制段连接。The anti-detachment anchoring mechanism applied to an implanted prosthesis according to claim 1, wherein the other end of the anchoring member is connected to the valve sewing segment after passing through the anchoring area and the heart tissue.
  8. 根据权利要求1所述的一种应用在植入假体上的防脱锚定机构,其中,所述防脱件的另一端依次穿过锚定区域、心脏组织后,最终与所述锚定区域连接。The anti-dropping anchoring mechanism applied to an implanted prosthesis according to claim 1, wherein the other end of the anti-dropping piece passes through the anchoring region and the heart tissue in sequence, and finally connects with the anchoring member. regional connection.
  9. 根据权利要求1所述的一种应用在植入假体上的防脱锚定机构,其中,所述防脱锚定机构还包括限位件,所述锚定件一端和防脱件一端分别与所述限位件固定连接。The anti-dropping anchoring mechanism applied to an implanted prosthesis according to claim 1, wherein the anti-dropping anchoring mechanism further comprises a limiting member, and one end of the anchoring member and one end of the anti-dropping member are respectively fixedly connected with the limiter.
  10. 根据权利要求1所述的一种应用在植入假体上的防脱锚定机构,其中,所述锚定件另一端的端部设置有倒刺结构或者所述锚定件上均布设置有微刺,或者所述防脱件另一端的端部设置有倒刺结构或者所述防脱件上均布设置有微刺。The anti-detachment anchoring mechanism applied to an implanted prosthesis according to claim 1, wherein the end of the other end of the anchoring member is provided with a barb structure, or the anchoring member is evenly arranged on the anchoring member There are micro-thorns, or the end of the other end of the anti-dropping member is provided with a barb structure, or the anti-dropping member is evenly provided with micro-thorns.
PCT/CN2021/114062 2020-08-31 2021-08-23 Anti-detachment anchoring mechanism applied to implanted prosthesis WO2022042478A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN202021856849.6 2020-08-31
CN202021856849.6U CN212490265U (en) 2020-08-31 2020-08-31 Anti-drop anchoring mechanism applied to implanted prosthesis

Publications (1)

Publication Number Publication Date
WO2022042478A1 true WO2022042478A1 (en) 2022-03-03

Family

ID=74385310

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2021/114062 WO2022042478A1 (en) 2020-08-31 2021-08-23 Anti-detachment anchoring mechanism applied to implanted prosthesis

Country Status (2)

Country Link
CN (1) CN212490265U (en)
WO (1) WO2022042478A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN212490265U (en) * 2020-08-31 2021-02-09 宁波健世生物科技有限公司 Anti-drop anchoring mechanism applied to implanted prosthesis

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104055600A (en) * 2014-07-07 2014-09-24 宁波健世生物科技有限公司 Repairing system provided with anchoring device and used for preventing valve regurgitation
WO2017042754A2 (en) * 2015-09-10 2017-03-16 Infinity Patent Holdco Llc Multi-aperture sling for mitral heart valves
CN108618871A (en) * 2017-03-17 2018-10-09 沃卡尔有限公司 Bicuspid valve with multi-direction anchor portion or tricuspid valve repair system
CN109688978A (en) * 2016-09-01 2019-04-26 美敦力瓦斯科尔勒公司 Heart valve prosthesis and independent support lug for attaching to heart valve prosthesis
CN212346819U (en) * 2020-08-31 2021-01-15 宁波健世生物科技有限公司 Multidimensional fixed heart valve prosthesis
CN212490265U (en) * 2020-08-31 2021-02-09 宁波健世生物科技有限公司 Anti-drop anchoring mechanism applied to implanted prosthesis
CN113413240A (en) * 2020-08-31 2021-09-21 宁波健世科技股份有限公司 Multidimensional fixed heart valve prosthesis
CN113425459A (en) * 2020-08-31 2021-09-24 宁波健世科技股份有限公司 Anti-drop anchoring mechanism applied to implanted prosthesis

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104055600A (en) * 2014-07-07 2014-09-24 宁波健世生物科技有限公司 Repairing system provided with anchoring device and used for preventing valve regurgitation
WO2017042754A2 (en) * 2015-09-10 2017-03-16 Infinity Patent Holdco Llc Multi-aperture sling for mitral heart valves
CN109688978A (en) * 2016-09-01 2019-04-26 美敦力瓦斯科尔勒公司 Heart valve prosthesis and independent support lug for attaching to heart valve prosthesis
CN108618871A (en) * 2017-03-17 2018-10-09 沃卡尔有限公司 Bicuspid valve with multi-direction anchor portion or tricuspid valve repair system
CN212346819U (en) * 2020-08-31 2021-01-15 宁波健世生物科技有限公司 Multidimensional fixed heart valve prosthesis
CN212490265U (en) * 2020-08-31 2021-02-09 宁波健世生物科技有限公司 Anti-drop anchoring mechanism applied to implanted prosthesis
CN113413240A (en) * 2020-08-31 2021-09-21 宁波健世科技股份有限公司 Multidimensional fixed heart valve prosthesis
CN113425459A (en) * 2020-08-31 2021-09-24 宁波健世科技股份有限公司 Anti-drop anchoring mechanism applied to implanted prosthesis

Also Published As

Publication number Publication date
CN212490265U (en) 2021-02-09

Similar Documents

Publication Publication Date Title
US20210322164A1 (en) Valve replacement systems and methods
US11419722B2 (en) Device, system, and method for transcatheter treatment of valve regurgitation
US20210307900A1 (en) Implant for heart valve
US7316706B2 (en) Tensioning device, system, and method for treating mitral valve regurgitation
JP4685630B2 (en) Method and apparatus for remodeling extravascular tissue structure
CN114617678A (en) Axisymmetric adjustable device for treating mitral regurgitation
WO2015191839A1 (en) Two stage anchor and mitral valve assembly
CN113301868A (en) Leaflet extensions of heart valve leaflets
WO2022042478A1 (en) Anti-detachment anchoring mechanism applied to implanted prosthesis
CN212346819U (en) Multidimensional fixed heart valve prosthesis
JP2023515809A (en) Transcatheter valve leads and valve elements
CN113425459A (en) Anti-drop anchoring mechanism applied to implanted prosthesis
CN214511424U (en) Valve presss from both sides with locking mechanism
US20240033084A1 (en) Mitral valve clip having locking mechanism
CN113413240A (en) Multidimensional fixed heart valve prosthesis
US20230210663A1 (en) Implantable cardiac valve improvement device and procedure for treating insufficient closing of a cardiac valve
US20200390552A1 (en) Implantable cardiac valve improvement device, system and procedure
US20200397581A1 (en) Implantable cardiac valve improvement device, system and procedure
CN115429489A (en) Implant
CA3109076A1 (en) An implantable cardiac valve improvement device, system and procedure

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 21860313

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 21860313

Country of ref document: EP

Kind code of ref document: A1